Advanced brachytherapy Physics

07-10 October, 2018
Valencia, Spain

TARGET GROUP

The course is primarily designed for medical physicists interested in expanding their knowledge in the field of brachytherapy physics. A basic background in the sub-specialty is required, as supported by (preferably) at least one year of experience in clinical practice, or participation in a relevant course (such as the Comprehensive and Practical Brachytherapy teaching course). The course could also serve as a refresher or an interactive update on recent developments in the field of brachytherapy for senior medical physicists.

FACULTY

Course director
Dimos Baltas, Physicist, University of Freiburg, Freiburg (DE)

Teachers
•    Luc Beaulieu, Physicist, Centre Hospitalier Universitaire de Quebec, Quebec (CA)
•    Nicole Nesvacil, Physicist,  Medizinische Universität Wien, (Vienna, AT)
•    Panagiotis Papagiannis, Physicist, National and Kapodistrian University of Athens, Athens (GR)
•    Mark Rivard, Physicist, Tufts University School of Medicine, Boston (USA)

Local organisers
•    Jose Perez-Catalayud, Physicist, Hospital Universitario La Fe, Valencia
•    Facundo Ballester, Physicist, University of Valencia

COURSE AIM/RATIONALE

The course aims to:
•  Expand on the physics background of recent developments in conventional and contemporary dosimetry methods in modern brachytherapy (computational and experimental)
•  Provide a detailed review of modern 3D treatment planning techniques and prescription concepts including: imaging, anatomy segmentation and source localisation methods, optimisation methods and strategies, treatment plan evaluation, the need for quality assurance, and concepts of risk assessment
•  Provide an overview of essential quality assurance aspects, in vivo dosimetry, treatment verification techniques and associated recent developments
•  Review available knowledge on uncertainties and their clinical impact in modern brachytherapy
•  Offer an overview of upcoming technological advancements in implantation and treatment delivery.